S1736 Mirikizumab Demonstrates Durable and Sustained Maintenance of Endoscopic and Histologic Outcomes at 4 Years in Patients With Moderately-to-Severely Active Ulcerative Colitis: LUCENT-3 Open-Label Extension Study
Year: 2025
Type: conference-abstract
Authors: Simon Travis, Bruce E. Sands, Laurent Peyrin-Biroulet, Alissa Walsh, Bram Verstockt, Kim McGinnis, Anthony Keohane, Deborah A. Fisher, Guanglei Yu, Aline Charabaty
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7111366935
Cites:
Cited by:
Related to: